K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study

被引:254
|
作者
Brink, M
de Goeij, AFPM
Weijenberg, MP
Roemen, GMJM
Lentjes, MHFM
Pachen, MMM
Smits, KM
de Bruïne, AP
Goldbohm, RA
van den Brandt, PA
机构
[1] Maastrict Univ, Dept Epidemiol, NUTRIM, NL-6200 MD Maastricht, Netherlands
[2] Maastrict Univ, Dept Pathol, GROW, Maastricht, Netherlands
[3] TNO Nutr & Food Res, NL-3700 AJ Zeist, Netherlands
关键词
D O I
10.1093/carcin/bgg009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Activation of K-ras oncogene has been implicated in colorectal carcinogenesis, being mutated in 30-60% of the adenocarcinomas. In this study, 737 incident colorectal cancer (CRC) patients, originating from 120 852 men and women (55-69 years at baseline) participating in the Netherlands Cohort Study (NLCS), were studied in order to evaluate subgroups with respect to K-ras mutation status. Mutation analysis of the exon 1 fragment of the K-ras oncogene, spanning codons 8-29, was performed on archival colorectal adenocarcinoma samples of all patients using macrodissection, nested PCR and direct sequencing of purified fragments. The method of mutation detection was validated by the confirmation of reported K-ras status in CRC cell lines, a good correlation between fresh-frozen and routinely fixed, paraffin-embedded tissue, a detection limit of 5% mutated DNA and a good reproducibility. Various types of K-ras mutations were evaluated with respect to tumour sub-localization, Dukes' stage and tumour differentiation. In 37% (271/737) of the patients, the exon 1 fragment of K-ras gene was found to be mutated. The predominant mutations are G>A transitions and G>T transversions, and codons 12 and 13 are the most frequently affected codons. Patients with a rectal tumour were found to have the highest frequency of G>T transversions as compared with patients with a colon or rectosigmoid tumour. This difference appeared to be confined to women with a rectal tumour harbouring G>T transversions. No significant differences were observed for Dukes' stage with respect to types of K-ras mutation, which does not support direct involvement of the K-ras oncogene in adenocarcinoma progression. The equal distribution of K-ras mutations among cases with or without a family history of colorectal cancer argues against an important role for this mutation in familial colorectal cancer, and could imply that K-ras mutations are more probably involved in environmental mechanisms of colorectal carcinogenesis.
引用
收藏
页码:703 / 710
页数:8
相关论文
共 50 条
  • [41] Absence of K-Ras mutations in colorectal cancer is associated with EGFR overexpression
    Melucci, E.
    Dimartino, V.
    Diodoro, M. G.
    D'Alicandro, V.
    Di Benedetto, A.
    Ercolani, C.
    Antoniani, B.
    Cognetti, F.
    Garufi, C.
    Pescarmona, E.
    Mottolese, M.
    VIRCHOWS ARCHIV, 2012, 461 : S183 - S184
  • [42] K-ras mutations in pancreatic cancer
    Grady, M
    Gaut, A
    Liu, JR
    Zhang, YP
    Zhang, H
    Weydert, C
    Domann, F
    Oberley, L
    Cullen, J
    FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 : S440 - S440
  • [43] The Biology of K-Ras and B-Raf Mutations in Colorectal Cancer
    Jiang, Yixing
    Mackley, Heath
    Cheng, Hua
    Ajani, Jaffer A.
    CURRENT COLORECTAL CANCER REPORTS, 2010, 6 (04) : 206 - 211
  • [44] Frequency of K-ras mutations in patients with colorectal cancer in a Mexican population
    Martinez-Garza, SG
    Nunez-Salazar, AJ
    Calderon-Garciduenas, AL
    Bosques-Padilla, FJ
    Niderhauser-Garcia, A
    Barrera-Saldana, HA
    GASTROENTEROLOGY, 1999, 116 (04) : A459 - A459
  • [45] Utilization of K-ras mutations as an indicator of local colorectal cancer spreading
    Lerner, A
    Cohen, O
    Kislitsin, D
    Lev, Z
    GASTROENTEROLOGY, 1999, 116 (04) : A452 - A452
  • [46] Validation of Blood Testing for K-ras Mutations in Colorectal and Pancreatic Cancer
    Rogosnitzky, Moshe
    Danks, Rachel
    ANTICANCER RESEARCH, 2010, 30 (07) : 2943 - 2947
  • [47] K-ras mutations and benefit from cetuximab in advanced colorectal cancer
    Karapetis, Christos S.
    Khambata-Ford, Shirin
    Jonker, Derek J.
    O'Callaghan, Chris J.
    Tu, Dongsheng
    Tebbutt, Niall C.
    Simes, R. John
    Chalchal, Haji
    Shapiro, Jeremy D.
    Robitaille, Sonia
    Price, Timothy J.
    Shepherd, Lois
    Au, Heather-Jane
    Langer, Christiane
    Moore, Malcolm J.
    Zalcberg, John R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (17): : 1757 - 1765
  • [48] Characterisation of under-represented K-ras mutations in colorectal cancer
    Ellison, G
    Clayton, SJ
    Fox, JC
    Little, S
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A65 - A65
  • [49] SAMPLING METHOD AS A KEY FACTOR IN IDENTIFYING K-RAS ONCOGENE MUTATIONS IN PRENEOPLASTIC COLORECTAL LESIONS
    RONAI, Z
    MINAMOTO, T
    BUTLER, R
    TOBI, M
    LUO, FQ
    ZANG, E
    ESUMI, H
    SUGIMURA, T
    CANCER DETECTION AND PREVENTION, 1995, 19 (06): : 512 - 517
  • [50] INCREASED PREVALENCE OF K-RAS ONCOGENE MUTATIONS IN LUNG ADENOCARCINOMA
    MILLS, NE
    FISHMAN, CL
    ROM, WN
    DUBIN, N
    JACOBSON, DR
    CANCER RESEARCH, 1995, 55 (07) : 1444 - 1447